Bottom line
How much do SCHLX and LOGSX overlap?
37% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 47.9% of SCHLX's assets and 54.0% of LOGSX's. They share a meaningful core but differ in the rest of the portfolio.
SCHLX holds far more positions (65 vs 28), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SCHLX and LOGSX have in common
| Holding | % of SCHLX | % of LOGSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.85% | 1.99% | 1.99% |
| Johnson & Johnson | 6.19% | 3.77% | 3.77% |
| Merck & Co Inc | 4.85% | 3.16% | 3.16% |
| Novartis AG | 2.90% | 4.67% | 2.90% |
| Amgen Inc | 2.88% | 4.86% | 2.88% |
| Gilead Sciences Inc | 2.78% | 3.50% | 2.78% |
| Intuitive Surgical Inc | 2.69% | 2.99% | 2.69% |
| Vertex Pharmaceuticals Inc | 2.45% | 3.26% | 2.45% |
| McKesson Corp | 2.05% | 4.53% | 2.05% |
| Novo Nordisk A/S | 1.73% | 2.51% | 1.73% |
| Bristol-Myers Squibb Co | 1.50% | 4.02% | 1.50% |
| Regeneron Pharmaceuticals Inc | 1.43% | 4.43% | 1.43% |
| Cardinal Health Inc | 1.34% | 5.86% | 1.34% |
| Cencora Inc | 1.26% | 4.46% | 1.26% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SCHLX
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Stryker Corp — 2.61%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- Boston Scientific Corp — 2.10%
- Medtronic PLC — 1.54%
- Roche Holding AG — 1.24%
- Pfizer Inc — 1.17%
Only in LOGSX
- N/a — 6.91%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Lantheus Holdings Inc — 4.68%
- National Healthcare Corp — 3.87%
- Medpace Holdings Inc — 3.69%
- Cigna Group (the) — 3.46%
- Incyte Corp — 3.30%
- Medtronic Plc — 3.01%
- Labcorp Holdings Inc — 2.29%
Asset mix
| Asset type | SCHLX | LOGSX |
|---|---|---|
| Stocks | 99.6% | 97.2% |
| Repurchase agreements | — | 6.9% |
| Cash & short-term funds | 0.5% | 1.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | SCHLX | LOGSX |
|---|---|---|
| US | 85.7% | 89.7% |
| IE | 1.5% | 8.8% |
| CH | 5.2% | 4.7% |
| GB | 3.8% | — |
| DK | 1.7% | 2.5% |
| FR | 1.0% | — |
| NL | 1.0% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do SCHLX and LOGSX overlap?
What stocks do SCHLX and LOGSX have in common?
Should I own both SCHLX and LOGSX?
Which holds more stocks, SCHLX or LOGSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.